Saturday 19 August 2017 The one stop source for free breaking news, expert analysis, and videos on AIM and LSE listed shares

Son of the Knob Park Ponzi: Quindell fraudster Rob Terry launches Quob Park Health

By Tom Winnifrith, The Sheriff of AIM | Sunday 4 December 2016

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Oh what tangled webs we weave, eh Mr Terry? Not distracted by the ongoing Serious Fraud Office investigation that will see him end up in jail, Rob Terry has a new venture. Natch it is one based on an old fraud but that probably won't deter some folks.

While his existing Quob Park Estates makes vast paper profits through accounting chicanery while supporting Rob's private vineyard, the great man has a new venture Quob Park Health. The COO is Rod Cameron, Terry's "Executive assistant" at Quenron and the man who first stated that Terry was a 2+2 can = 5 sort of man. The rest of the team feature a number of familiar faces from Knob Park and Quenron and, of course, the lovely Tracey, Rob's Mrs.

What does Knob Park Health do? Er well it has a nice new website. And it spouts lots of phrases which Rob Terry understands but we mere mortals might struggle to actually translate into meaningful English. But who cares? Just trust Rob Terry right? After Quenron what could possibly go wrong?

Quob Park Health – Industry leading health management solutions designed for the healthcare industry and associated participants

Our innovative QPH Frameworks software provides a comprehensive suite of solutions for the healthcare industry, an industry where a continuing shortage of professional carers and doctors equals a loss of quality for patient care.

Er...come again Rob?

Nursing Care: QPH Frameworks Solutions optimise the processes and structures of the care environment and generates new sources of revenue for nursing care facilities.

Families: QPH Frameworks offers the best care for your dependants, at any time, by using technology to enhance communications capabilities. Customers can play an important part in the care of their relatives by being directly linked to doctors and caregivers.

Modular Solution for Doctors: QPH Frameworks creates conditions for a multimedia real-time exchange between doctors, patients, relatives, nursing care facilities, hospitals, emergency facilities and pharmacies.

At this point Rob has already saved the NHS a few quid as I have lost the will to live and booked into Dignitas. What utter gibberish.

So how is Knob Park Health doing? Well it is hard to say as it was only set up on March 31 2016. But it went intio life very quickkly on April 13 as you can see in the release below:

Quob Park Health buys certain Biosign/AioMed IPR, Assets and Contracts

In January 2016 , the Board of Directors of Biosign concluded that there was no alternative other than to sell its German investments to Quob Park Estate (“QPE”) with the potential to provide an opportunity to repay creditors and provide a return of capital to shareholders.

Pursuant to a letter of intent dated January 21, 2016 (“LOI”), Biosign intended to sell to QPE its German investments by agreeing to sell 70% of the shares issued and outstanding of Aiomed GmbH (“Aiomed”) and 100% of the shares issued and outstanding of Biosign Europe Technologies GmbH (“Biosign Europe”). Biosign owns only 38.5% of the issued and outstanding shares of Aiomed and does not have control of its operations. Biosign anticipated to acquire additional shares of Aiomed in order to sell 70% of said shares to QPE and had entered into a non-binding letter of intent to acquire additional Aiomed shares but was not able to negotiate a final agreement.

In conjunction the proposed purchase of Biosign’s German operations, QPE had agreed to provide loans to Biosign up to €650,000 (circa CAD$1 million ) to fund the overall operations of Biosign (“QPE Loan”). Since the completion of the LOI, QPE advanced to Biasing Europe €450,000 under the QPE Loan which is secured by a first charge over all the shares in Aiomed and Biosign Europe held by Biosign as well as an assignment of all the intercompany loans payable to Biosign and is also guaranteed by the Company. Unfortunately, after completing its due diligence process, QPE decided that the original proposed transaction did not meet its requirements and combined with the fact that Biosign was unable to secure additional Aiomed shares to complete the purchase transaction, QPE decided to terminate its funding. The assets of Aiomed were transferred to QPE in return for royalties payable to Aiomed based on future revenue.

Biosign cannot currently collect any of the intercompany loans and fees due from Aiomed and Biosign Europe and cannot predict whether any such fees and loans will ever be repaid. Since Biosign has currently no financial means to meet its obligations, the Company is forced to cease operations.

Er... oh well they look like quality assets don't they. But does the name Biosign not ring a bell? Of course it was a Quindell (QPP) investment and one where Rob happily committed accounting fraud creating bogus profits which we exposed. The PWC review vindicated our expose in full.

Leopards and spots and all of that. What can possibly go wrong?

Filed under:

Never miss a story.

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

More on QPP


Comments are turned off for this article.

Site by Everywhen